Geneva Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,218
| Closed | -$617K | – | 81 |
|
|
2023
Q3 | $617K | Sell |
1,218
-1,574
| -56% | -$797K | 0.41% | 45 |
|
|
2023
Q2 | $1.46M | Sell |
2,792
-100
| -3% | -$52.2K | 0.95% | 33 |
|
|
2023
Q1 | $1.67M | Sell |
2,892
-20
| -0.7% | -$11.5K | 1.43% | 30 |
|
|
2022
Q4 | $1.6M | Sell |
2,912
-1,123
| -28% | -$618K | 1.51% | 24 |
|
|
2022
Q3 | $2.05M | Buy |
4,035
+24
| +0.6% | +$12.2K | 2.34% | 17 |
|
|
2022
Q2 | $2.18M | Sell |
4,011
-222
| -5% | -$121K | 2.14% | 19 |
|
|
2022
Q1 | $2.5M | Sell |
4,233
-1,008
| -19% | -$595K | 1.55% | 25 |
|
|
2021
Q4 | $3.5M | Buy |
5,241
+28
| +0.5% | +$18.7K | 1.66% | 22 |
|
|
2021
Q3 | $2.98M | Buy |
5,213
+460
| +10% | +$263K | 1.41% | 29 |
|
|
2021
Q2 | $2.4M | Sell |
4,753
-15
| -0.3% | -$7.57K | 1.1% | 31 |
|
|
2021
Q1 | $2.18M | Sell |
4,768
-72
| -1% | -$32.9K | 1.13% | 31 |
|
|
2020
Q4 | $2.25M | Sell |
4,840
-1,670
| -26% | -$778K | 1.19% | 31 |
|
|
2020
Q3 | $2.87M | Sell |
6,510
-130
| -2% | -$57.4K | 1.76% | 24 |
|
|
2020
Q2 | $2.41M | Sell |
6,640
-25
| -0.4% | -$9.06K | 1.69% | 26 |
|
|
2020
Q1 | $1.89M | Sell |
6,665
-460
| -6% | -$130K | 2.69% | 17 |
|
|
2019
Q4 | $2.32M | Sell |
7,125
-85
| -1% | -$27.6K | 1.6% | 26 |
|
|
2019
Q3 | $2.1M | Buy |
7,210
+125
| +2% | +$36.4K | 1.63% | 26 |
|
|
2019
Q2 | $2.08M | Sell |
7,085
-3,225
| -31% | -$947K | 1.68% | 24 |
|
|
2019
Q1 | $2.73M | Buy |
10,310
+1,165
| +13% | +$308K | 2.32% | 16 |
|
|
2018
Q4 | $2.05M | Buy |
9,145
+3,400
| +59% | +$761K | 2.37% | 16 |
|
|
2018
Q3 | $1.4M | Buy |
+5,745
| New | +$1.4M | 1.08% | 35 |
|